Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Histologically proven advanced epithelial ovarian cancer (International Federation of Gynecology and Obstetrics - FIGO stage III–IV). • Unresectable disease at primary assessment confirmed either by laparoscopy, laparotomy, or combined CT scan evaluation and cytology. • Cases that respond to neoadjuvant chemotherapy with complete or partial response to treatment according to the Response Evaluation Criteria of Solid Tumours (RECIST). • Patients with good performance status < 2
Exclusion criteria
Exclusion criteria: • Early/resectable epithelial ovarian cancer cases. • Borderline or non-epithelial ovarian tumours. • Progressive disease after neoadjuvant chemotherapy. • Patients with bad performance status > 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oncologic outcomes (short-term, between 6-24 months) have been recorded and compared between the two groups regarding: 1.Disease free and overall survival of patients. 2.Time of recurrence (if any). 3.Site of recurrence (if any). | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical outcomes have been recorded and compared between the two groups regarding: 1. Completeness of surgery 2. Integrity of tumour specimen 3. Lymph Node harvest 4. Peritoneal biopsy harvest 5. Operative time and complications 6. Amount of blood loss and transfusion 7. Duration of hospital stay 8. Postoperative complications | — |
Countries
Egypt
Contacts
Surgical Oncology Specialist